PharVision Advisers’s Broadstone Net Lease BNL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-21,165
Closed -$340K – 670
2025
Q2
$340K Buy
+21,165
New +$339K 0.49% 57
2025
Q1
– Sell
-14,413
Closed -$229K – 296
2024
Q4
$229K Buy
+14,413
New +$251K 0.19% 247

Other funds holding BNL

PharVision Advisers's BNL Position: Q3 2025 in Review

PharVision Advisers sold out of Broadstone Net Lease (BNL) in Q3 2025, closing a stake of 21,165 shares — an estimated $340K sold.

PharVision Advisers first reported a position in BNL in Q4 2024 and held it in 2 quarters. The position peaked at $340K in Q2 2025. 331 funds tracked by Wall St. Rank hold BNL as of Q3 2025.

  • PharVision Advisers reported no remaining Broadstone Net Lease position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 21,165 Broadstone Net Lease shares in Q3 2025, an estimated $340K.
  • PharVision Advisers first reported a position in Broadstone Net Lease in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Broadstone Net Lease position peaked at $340K in Q2 2025.
  • 331 funds tracked by Wall St. Rank held Broadstone Net Lease as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.